Inflammatory and hemostatic abnormality in atrial fibrillation patients at tertiary care hospital, Mardan

A descriptive cross sectional study

https://doi.org/10.53730/ijhs.v5nS1.14698

Authors

  • Noorul Hadi Bacha Khan Medical College, Mardan - Pakistan
  • Asfandiyar Mardan Medical Complex, Mardan - Pakistan
  • Mohammad Qasim Khan Paeds BkMC /MMC, Mardan - Pakistan
  • Suhanuddin Gajju Khan Medical College, Swabi - Pakistan
  • Jehandad Mardan Medical Complex, Mardan - Pakistan
  • Sarmad Raza Mardan Medical Complex, Mardan - Pakistan
  • Faizullah Mardan Medical Complex, Mardan - Pakistan

Keywords:

atrial fibrillation, CRP, D – dimers, inflammatory marker, coagulation activation marker

Abstract

Objective: To determine the levels of C-reactive protein (CRP) and D-dimers in patients presenting with atrial fibrillation. Study design: Descriptive Cross sectional/Observational. Place and duration of study: From Januarty 2019 to June 2020, the study was carried out in the cardiology and pathology departments of Mardan Medical Complex and Bacha Khan Medical College Mardan. Material and Methods: This study included a total of 100 patients with atrial fibrillation, with 50 people serving as the control group. The levels of CRP and D-dimers were determined in all cases. Results: 35% of the individuals in this study had increased CRP levels. The average CRP level was 2.99 +/- 0.652mg, which was substantially higher than in the control group. Similarly, 45% of patients had an increased D-dimer level. Among these individuals, 30% had D-dimer levels between 250 and 500mg, and 50% had levels between 500 and 1000 ng/ml, which were considerably higher than the control group. Conclusion: According to the findings of the study, atrial fibrillation is related with both inflammatory and coagulation abnormalities, as seen by higher CRP and D-dimer levels. Both these indicators are thromboembolic risk factors. 

Downloads

Download data is not yet available.

References

Calm AJ,LIPJY, (60,61) atar d, SHEET all .Ese Guidelines for the management of atrial fibrillation developed with special contribution of the European heart rhythm association eur heart j 2012; 33; 2719---2747

xufx, Jiang LF, OU MJ, zhang ZH. THE association between mean platlet valume and chronic atrial fibrillation and the presence of thrombotic events. J.bio Rep 2015;3(3): 388-394

KIREHOF P, (63)A baxy crijins H, came D,Dimer he. Et all out come parameters for traits in atrial fibrillation atrial fibrillation and competence network and the (64) HEART rhythm association . eur heart J 2007; 28: 2803---2817.

Dense E,montagnana M, (65) G, LIPPI G ,hypercoagulability, D-dimer and atrial fibrillation an overview of biological and clinical evidence. Ann me 2014,2028

lipping, franehini M. pathogenesis of venous thromboembolism. Semin thromb hernost . 2008;34;747----761.

Madrid AH, MORO C atrial fibrillation and C- reactive protein. J. Am collared 2007;49: 1649-1650

D-dimer j, panaretoy M. C – reactive protein and paroxysmal atrial fibrillation. Evidence of the implications of an inflammation process in, paroxysmal atrial fibrillation acta cardiologiea 2001; 56; 375-380.

Boos, C., Anderson, RA., & Lip, G. (2006). Is atrial fibrillation an inflammatory disorder? European Heart Journal, 27(2), 136-49. https://doi.org/10.1093/eurheartj/ehi645

norlam os, ukog o , lepajarvl. S , kentta T keviniemi A, JUNTILA J etal. Association of ST2 and his CRP levels with new onset. Atrial fibrillation in coronary artery disease. Int J. card. 2017; 248: 173-178

su ,fe L DX SUN XS, SHI YM , XUE HF, TENGES (66) ETAL . Atorvastatin treatment for atrial fibrillation reduces serum high sensitivity c- reactive proteins levels bio med res int 2015 article D 40 2481. http/ dx.doi org/ 10-1155/2015/402481.

liut li g li l korantzopulose. P association between C- reactive proteins. P recurrence of atrial fibrillation after successful electrical cardioversion a meta analysis J am coll cord 2007; 49; 1642-1648.

shoram G shetkar s, bhasin it juneya .R ramar krishan L NAIK n, etal high sensitive C- reactive protein and interleukin- 6 in atrial fibrillation with rheumatic mitral stenosis from Indian cohort . Indian hear-ting 2016;chttp/dx.doi.org/10-10.16/hy. 2016.12.006.(67)

Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder? Eur Heart J. 2006 Jan;27(2):136-49. doi: 10.1093/eurheartj/ehi645. Epub 2005 Nov 8. PMID: 16278230.

Lombardi F TUNDO f belleffi manteroa eril mvg . c- reactive protein but not atrial dysfunction predictors of atrial fibrillation after cardioversion in patient with preserve left Ventricular function. J. card. Vas med.2008;9: 581-588

marcue GM Wooley MA ,GIiddenD etal (68) 6 and atrial fibrillation in patients with coronary artery disease date from heart and soul study. Am heart J 2008; 155; 303-309.

Daudion M andereti F zamparelli etal (69) 6 levels and post operative atrial fibrillation is atrial fibrillation an inflammatory complication, circulation 2003;108: 195-199.

osmancik P PEROUTKA z buderap, herman D, stros P straka Z. changes in cytokine concentrations following successful ablation of atrial fibrillation. Eur cytokine neto 2010; 21:278-284

mahel, bergman FJ , chassany sollier DBC, simonall D rout L A multicentric prospective study in usual care . D – dimer cardiovascular events in patients with atrial fibrillation thrombosis reset 2012; 129: 693-699.

agneta S joras Oulrika A MIEHAEL e , d – dimer factor for cardiovascular and heats of anticoagulation therapy. A. RE LY sub-study . thrombosis and haemostatic is 2016; 115: 921-930

Danese. E mantagnation cervllin G lippi G hypercoagulability, D- dimer and atrial fibrillation an over of (70) and (71) (72) . ann med 2014; 46; 364- 37%

wan H wus, yang Y zhu J, ZHANG a , ling Y PLASMA d-dimer and the risk of left thrombus. A systemic review and meta analyses. Plos one 2017; 12:1-18;

albasheer IE , humeda AA, amofti AY. Evaluation of haemodialysis in sudanese. Patient pyrexy bio res 2016; 3; 16- 19

Body R, Allie B. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Negative D-dimer may allow safe early cardioversion of atrial fibrillation. Emerg Med J. 2007 Jun;24(6):432-5. doi: 10.1136/emj.2007.049510. PMID: 17513547; PMCID: PMC2658288.

Somlói M, Tomcsányi J, Nagy E, Bodó I, Bezzegh A. D-dimer determination as a screening tool to exclude atrial thrombi in atrial fibrillation. Am J Cardiol. 2003 Jul 1;92(1):85-7. doi: 10.1016/s0002-9149(03)00476-4. PMID: 12842257.

lip G does atrial fibrillation confer a hyper coagulable state. Lancet .995,346; 1313---1314.

akar JG jeske W , welber DJ. Acute onset human atrial fibrillation is associated with local cardiac patient activation and endothelial dysfunction. J Am coll cordial 2008;51: 1790---1793.

WU N, xub yang Y, wul (39), maxefal. Association of inflammation factors with occurrence and recurrence of atrial fibrillation . A meta analysis (40) cord . int J cardiol(?) 2013 ,169 .162—72.

GOUY, LIPGY. (41)-S inflammation in atrial fibrillation . J AMCOLL cardial 2012, 60, 2263—2270.

king DE, (42) LM , (43), acute management of atrial fibrillation part II (44) thrombotic complications, Am fam physician 2002,,66: 261---266.

Published

30-03-2021

How to Cite

Hadi, N., Asfandiyar, Khan, M. Q., Suhanuddin, Jehandad, Raza, S., & Faizullah. (2021). Inflammatory and hemostatic abnormality in atrial fibrillation patients at tertiary care hospital, Mardan: A descriptive cross sectional study. International Journal of Health Sciences, 5(S1), 862–868. https://doi.org/10.53730/ijhs.v5nS1.14698

Issue

Section

Peer Review Articles